Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
14,519,063
-
Share change
-
+4,183
-
Total reported value
-
$230,180,808
-
Price per share
-
$15.86
-
Number of holders
-
75
-
Value change
-
-$18,475,024
-
Number of buys
-
54
-
Number of sells
-
26
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q1 2016
As of 31 Mar 2016,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,519,063 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT CO, VANGUARD GROUP INC, JANUS CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., BAKER BROS. ADVISORS LP, Foresite Capital Management III, LLC, WELLINGTON MANAGEMENT GROUP LLP, and Iguana Healthcare Management, LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.